ASTP2
Mexico·Clase I·III. DIAGNOSTIC AGENTS·PRODUCTOSROCHE, S.A. DE C.V.·Registered June 21, 2022PRUEBAINVITROPARALADETERMINACIÓNCUANTITATIVADE LA ASPARTATO AMINOTRANSFERASA (AST) CONACTIVACIÓN POR FOSFATO DE PIRIDOXAL EN SUERO YPLASMA HUMANOS EN LOS SISTEMAS ROCHE COBAS C.AGENTEDEDIAGNÓSTICOPARAUSOINVITRO. PARAUSOEXCLUSIVO EN LABORATORIOS CLÍNICOS O DE GABINETES.
INVITRO TEST FOR THE QUANTITATIVE DETERMINATION OF ASPARTATE AMINOTRANSFERASE (AST) PYRIDOXAL PHOSPHATE ACTIVATION IN HUMAN SERUM AND PLASMA IN ROCHE COBAS SYSTEMS C.DIAGNOSTIC AGENT FOR INVITRO USE. FOR EXCLUSIVE USE IN CLINICAL LABORATORIES OR CABINETS.
- Risk Class / Clase de Riesgo
- Clase I
- Product Type (Spanish)
- III. AGENTES DE DIAGNÓSTICO
- Product Type (English)
- III. DIAGNOSTIC AGENTS
- Trade Name (Spanish)
- PRUEBA PARA LADETERMINACIÓN DEASPARTATOAMINOTRANSFERASA (AST)
- Trade Name (English)
- ASPARTATE AMINOTRANSFERASE (AST) TEST
- Analysis ID
- 519R2022 SSA
- Registration Date
- June 21, 2022
- Name (Spanish)
- PRODUCTOSROCHE, S.A. DE C.V.
- Name (English)
- PRODUCTOSROCHE, S.A. DE C.V.
Access comprehensive regulatory information for ASTP2 (ASTP2) in the Mexico medical device market through Pure Global AI's free database. This Clase I medical device is registered under COFEPRIS analysis ID 519R2022 SSA and manufactured by PRODUCTOSROCHE, S.A. DE C.V.. The device was registered on June 21, 2022.
This page provides complete registration details including product type (III. DIAGNOSTIC AGENTS), manufacturer information, and regulatory compliance data from the official Mexico COFEPRIS medical device database. Pure Global AI offers free access to Mexico's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate COFEPRIS regulations efficiently.